Read my topic. The trial that was reported is not related to NBS in any way. And the trial results are amazing any way. People who don't have a scientific background should not invest in biotech stocks. They don't understand good or bad news and listen to other people who don't understand it either. A study of 17 patients is not enough to determine improvement in heart function.